Current issues around the pharmacotherapy of ADHD in children and adults

Pharmacy World and Science

Volumn 31, Issue 5, 2009, Pages 509-516

  Meijer, Willemijn M ^a   Faber, Adrianne ^b   Van Den Ban, Els ^c   Tobi, Hilde ^d  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^c Altrecht   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Adults; Attention deficit hyperactivity disorder; Children and adolescents; Pharmacotherapy

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DESIPRAMINE; DEXAMPHETAMINE; MELATONIN; METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ADULT; ANOREXIA; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CAPSULE ENDOSCOPE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; GROUPS BY AGE; GROWTH; HEART RATE; HEART RHYTHM; HUMAN; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NOTE; NUTRITIONAL STATUS; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SUDDEN DEATH; SUICIDAL IDEATION;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HUMANS; PROPYLAMINES; TREATMENT OUTCOME;

EID: 69249214022     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-009-9302-3     Document Type: Note

References (72)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author: American Psychiatric Association; 1994.
2. LS Goldman M Genel RJ Bezman PJ Slanetz 1998 Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on scientific affairs, American Medical Association J Am Med Assoc 279 14 1100 1107 10.1001/jama.279.14.1100 (Pubitemid 28177819)
3. Mental health in the United States 2005 Prevalence of diagnosis, medication treatment for attention-deficit/hyperactivity disorder - United States, 2003 MMWR Morb Mortal Wkly Rep 4 34 842 847
4. Barkley R. Attention-deficit hyperactivity disorder. A handbook for diagnosis and treatment. 3rd ed. New York: The Guilford Press; 2006.
5. L Bren 2004 ADHD: not just for kids anymore FDA Consum 38 6 14 20
6. M Weiss C Murray 2003 Assessment and management of attention-deficit hyperactivity disorder in adults CMAJ 168 6 715 722
7. PH Wender LE Wolf J Wasserstein Adults with ADHD 2001 An overview Ann N Y Acad Sci 931 1 16
8. RC Kessler LA Adler R Barkley J Biederman CK Conners SV Faraone, et al. 2005 Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication Biol Psychiatry 57 11 1442 1451 10.1016/j.biopsych.2005.04.001 (Pubitemid 40798566)
9. P Rasmussen C Gillberg 2000 Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study J Am Acad Child Adolesc Psychiatry 39 11 1424 1431 10.1097/00004583-200011000-00017
10. CA Riccio M Wolfe B Davis C Romine C George D Lee 2005 Attention deficit hyperactivity disorder: manifestation in adulthood Arch Clin Neuropsychol 20 2 249 269 10.1016/j.acn.2004.07.005 (Pubitemid 40222162)
11. J Biederman E Mick SV Faraone 2000 Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type Am J Psychiatry 157 5 816 818 10.1176/appi.ajp.157.5.816 (Pubitemid 30249663)
12. de Graaf R, Kessler RC, Fayyad J, Ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008;65:835-42.
13. J Fayyad R De Graaf R Kessler J Alonso M Angermeyer K Demyttenaere, et al. 2007 Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Br J Psychiatry 190 402 409 10.1192/bjp.bp.106.034389 (Pubitemid 46706952)
14. RC Kessler L Adler R Barkley J Biederman CK Conners O Demler, et al. 2006 The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 163 4 716 723 10.1176/appi.ajp.163.4.716 (Pubitemid 44464584)
15. JJ Kooij JK Buitelaar EJ van den Oord JW Furer CA Rijnders PP Hodiamont 2005 Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults Psychol Med 35 6 817 827 10.1017/S003329170400337X (Pubitemid 40873382)
16. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement. 1998;16(2):1-37.
17. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000;105(5):1158-70. doi: 10.1542/peds.105.5.1158.
18. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033-44. doi: 10.1542/peds.108.4.1033. (Pubitemid 32947681)
19. E Taylor M Dopfner J Sergeant P Asherson T Banaschewski J Buitelaar, et al. 2004 European clinical guidelines for hyperkinetic disorder-first upgrade Eur Child Adolesc Psychiatry 13 Suppl 1 I7 I30 10.1007/s00787-004-1002-x (Pubitemid 39172160)
20. S Kutcher M Aman SJ Brooks J Buitelaar E van Daalen J Fegert, et al. 2004 International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions Eur Neuropsychopharmacol 14 1 11 28 10.1016/S0924-977X(03)00045-2 (Pubitemid 37495027)
21. Multidisciplinaire richtlijn ADHD: richtlijn voor de diagnostiek en behandeling van ADHD bij kinderen en jeugdigen. Utrecht: Trimbos-instituut. 2005.
22. T Spencer J Biederman T Wilens M Harding D O'Donnell S Griffin 1996 Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle J Am Acad Child Adolesc Psychiatry 35 4 409 432 10.1097/00004583- 199604000-00008
23. HM Schachter B Pham J King S Langford D Moher 2001 How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis CMAJ 165 11 1475 1488
24. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073-86. doi: 10.1001/archpsyc.56.12.1073.
25. National Institute of Mental Health. Multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/ hyperactivity disorder. Pediatrics. 2004;113(4):754-61. doi: 10.1542/peds.113.4.754. (Pubitemid 38437380)
26. PS Jensen LE Arnold JM Swanson B Vitiello HB Abikoff LL Greenhill, et al. 2007 3-year follow-up of the NIMH MTA study J Am Acad Child Adolesc Psychiatry 46 8 989 1002 10.1097/CHI.0b013e3180686d48 (Pubitemid 47220683)
27. JH Newcorn CJ Kratochvil AJ Allen CD Casat DD Ruff RJ Moore, et al. 2008 Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response Am J Psychiatry 165 6 721 730 10.1176/appi.ajp.2007.05091676 (Pubitemid 351810541)
28. DJ Nutt K Fone P Asherson D Bramble P Hill K Matthews, et al. 2007 Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology J Psychopharmacol 21 1 10 41 10.1177/0269881106073219 (Pubitemid 46012081)
29. TE Wilens 2003 Drug therapy for adults with attention-deficit hyperactivity disorder Drugs 63 22 2395 2411 10.2165/00003495-200363220-00002 (Pubitemid 37392906)
30. DJ Safer JM Zito EM Fine 1996 Increased methylphenidate usage for attention deficit disorder in the 1990s Pediatrics 98 6 Pt 1 1084 1088
31. JM Zito DJ Safer S dosReis JF Gardner M Boles F Lynch 2000 Trends in the prescribing of psychotropic medications to preschoolers J Am Med Assoc 283 8 1025 1030 10.1001/jama.283.8.1025
32. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics. 2001;108(2):E25. doi: 10.1542/peds.108.2.e25.
33. AR Miller CE Lalonde KM McGrail RW Armstrong 2001 Prescription of methylphenidate to children and youth, 1990-1996 CMAJ 165 11 1489 1494
34. R Reid P Hakendorf B Prosser 2002 Use of psychostimulant medication for ADHD in South Australia J Am Acad Child Adolesc Psychiatry 41 8 906 913 10.1097/00004583-200208000-00008 (Pubitemid 38338069)
35. JM Zito DJ Safer S DosReis JF Gardner L Magder K Soeken, et al. 2003 Psychotropic practice patterns for youth: a 10-year perspective Arch Pediatr Adolesc Med 157 1 17 25
36. L Castle RE Aubert RR Verbrugge M Khalid RS Epstein 2007 Trends in medication treatment for ADHD J Atten Disord 10 4 335 342 10.1177/ 1087054707299597
37. A Faber LT den Berg PB van den Berg H Tobi 2005 Psychotropic co-medication among stimulant-treated children in the Netherlands J Child Adolesc Psychopharmacol 15 1 38 43 10.1089/cap.2005.15.38 (Pubitemid 40365912)
38. JG Hugtenburg ER Heerdink AC Egberts 2004 Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys Eur J Clin Pharmacol 60 5 377 379 10.1007/s00228-004-0765-9
39. D Coghill 2004 Use of stimulants for attention deficit hyperactivity disorder: FOR BMJ 329 7471 907 908 10.1136/bmj.329.7471.907
40. H Marcovitch 2004 Use of stimulants for attention deficit hyperactivity disorder: AGAINST BMJ 329 7471 908 909 10.1136/bmj.329.7471.908
41. JK Buitelaar A Rothenberger 2004 Foreword-ADHD in the scientific and political context Eur Child Adolesc Psychiatry 13 Suppl 1 I1 I6
42. DJ Safer 2000 Are stimulants overprescribed for youths with ADHD? Ann Clin Psychiatry 12 1 55 62
43. Buitelaar JK. Discussion of attention deficit-hyperactivity disorder (ADHD): facts, opinions and emotions. Ned Tijdschr Geneeskd. 2001;145(31):1485-9.
44. JM Rey MG Sawyer 2003 Are psychostimulant drugs being used appropriately to treat child and adolescent disorders? Br J Psychiatry 182 284 286 10.1192/bjp.182.4.284 (Pubitemid 36408275)
45. P Accardo TA Blondis 2001 What's all the fuss about Ritalin? J Pediatr 138 1 6 9 10.1067/mpd.2001.111505 (Pubitemid 32097134)
46. J Biederman T Wilens E Mick T Spencer SV Faraone 1999 Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder Pediatrics 104 2 e20 10.1542/peds.104.2.e20
47. RA Barkley M Fischer L Smallish K Fletcher 2003 Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study Pediatrics 111 1 97 109 10.1542/peds.111.1.97 (Pubitemid 36071038)
48. S Bogas 1997 "Diagnosis du jour?" Understanding attentional deficits can sharpen our treatment strategies Fam Ther Networker 21 63 67
49. RW Smelter BW Rasch 1996 Is attention deficit disorder becoming a desired diagnosis? Phi Delta Kappan 77 429 432
50. MJ Sciutto M Eisenberg 2007 Evaluating the evidence for and against the overdiagnosis of ADHD J Atten Disord 11 2 106 113 10.1177/1087054707300094
51. A Faber LJ Kalverdijk LT den Berg JG Hugtenburg RB Minderaa H Tobi 2006 Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care J Child Adolesc Psychopharmacol 16 4 432 440 10.1089/cap.2006.16.432 (Pubitemid 44681463)
52. J Biederman E Mick SV Faraone E Braaten A Doyle T Spencer, et al. 2002 Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic Am J Psychiatry 159 1 36 42 10.1176/appi.ajp.159.1.36 (Pubitemid 41070724)
53. J Gershon 2002 A meta-analytic review of gender differences in ADHD J Atten Disord 5 3 143 154 10.1177/108705470200500302 (Pubitemid 44844210)
54. TE Wilens SV Faraone J Biederman S Gunawardene 2003 Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 111 1 179 185 10.1542/peds.111.1.179 (Pubitemid 36071051)
55. TE Wilens LA Adler J Adams S Sgambati J Rotrosen R Sawtelle, et al. 2008 Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature J Am Acad Child Adolesc Psychiatry 47 1 21 31 10.1097/chi.0b013e31815a56f1
56. J Graham D Coghill 2008 Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management CNS Drugs 22 3 213 237 10.2165/00023210-200822030-00003 (Pubitemid 351263725)
57. S Cortese E Konofal N Yateman MC Mouren M Lecendreux 2006 Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature Sleep 29 4 504 511
58. KB Van der Heijden MG Smits EJ Van Someren KR Ridderinkhof WB Gunning 2007 Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia J Am Acad Child Adolesc Psychiatry 46 2 233 241 10.1097/01.chi.0000246055.76167.0d (Pubitemid 46148422)
59. DA Zachor AW Roberts JB Hodgens JS Isaacs J Merrick 2006 Effects of long-term psychostimulant medication on growth of children with ADHD Res Dev Disabil 27 2 162 174 10.1016/j.ridd.2004.12.004 (Pubitemid 43183618)
60. SV Faraone J Biederman CP Morley TJ Spencer 2008 Effect of stimulants on height and weight: a review of the literature J Am Acad Child Adolesc Psychiatry 47 9 994 1009 10.1097/CHI.0b013e31817e0ea7
61. A Poulton 2005 Growth on stimulant medication; clarifying the confusion: a review Arch Dis Child 90 8 801 806 10.1136/adc.2004.056952 (Pubitemid 41081356)
62. A Charach M Figueroa S Chen A Ickowicz R Schachar 2006 Stimulant treatment over 5 years: effects on growth J Am Acad Child Adolesc Psychiatry 45 4 415 421 10.1097/01.chi.0000199026.91699.20 (Pubitemid 43675546)
63. TJ Spencer SV Faraone J Biederman M Lerner KM Cooper B Zimmerman 2006 Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry 45 5 527 537 10.1097/01.chi. 0000205710.01690.d4 (Pubitemid 43756182)
64. SR Pliszka TL Matthews KJ Braslow MA Watson 2006 Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 45 5 520 526 10.1097/01.chi.0000205702.48324.fd (Pubitemid 43756181)
65. MD Rapport C Moffitt 2002 Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects Clin Psychol Rev 22 8 1107 1131
66. JF Wernicke D Faries D Girod J Brown H Gao D Kelsey, et al. 2003 Cardiovascular effects of atomoxetine in children, adolescents, and adults Drug Saf 26 10 729 740 10.2165/00002018-200326100-00006 (Pubitemid 36976134)
67. http://www.fda.gov/cder/drug/advisory/adderall.html. Accessed 3 Sep 2008.
68. E Wooltorton 2005 Suicidal ideation among children taking atomoxetine (Strattera) CMAJ 173 12 1447
69. ME Bangs S Tauscher-Wisniewski J Polzer S Zhang N Acharya D Desaiah, et al. 2008 Meta-analysis of suicide-related behavior events in patients treated with atomoxetine J Am Acad Child Adolesc Psychiatry 47 2 209 218 10.1097/chi.0b013e31815d88b2 (Pubitemid 351158789)
70. JJ Kooij H Burger AM Boonstra PD Van der Linden LE Kalma JK Buitelaar 2004 Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial Psychol Med 34 6 973 982 10.1017/S0033291703001776 (Pubitemid 39199967)
71. TJ Spencer LA Adler JJ McGough R Muniz H Jiang L Pestreich 2007 Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 61 12 1380 1387 10.1016/j.biopsych.2006.07.032 (Pubitemid 46855767)
72. RH Weisler J Biederman TJ Spencer TE Wilens SV Faraone AK Chrisman, et al. 2006 Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial CNS Spectr 11 8 625 639